Alcon Laboratories (U.K) Limited

Pentagon Park, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 7UD
Telephone: +44 (0)1442 341 234
Fax: +44 (0)1442 341 200

Summary of Product Characteristics last updated on the eMC: 06/01/2009
SPC Ilube Eye Drops


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

ILUBE 5% w/v Eye Drops, Solution


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Acetylcysteine 5.0% w/v

For excipients, see 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Eye Drops, Solution

A clear and colourless eye drops, solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Ilube Eye Drops are artificial tears with mucolytic and lubricant properties, indicated for the relief of dry eye syndromes associated with deficient tear secretion, impaired or abnormal mucus production.


Go to top of the page
4.2 Posology and method of administration

Ilube Eye Drops are administered by topical instillation into the conjunctival sac.

The usual dose is 1 or 2 drops instilled into the affected eye three or four times daily.


Go to top of the page
4.3 Contraindications

Known hypersensitivity to any component.


Go to top of the page
4.4 Special warnings and precautions for use

Ilube Eye Drops contain benzalkonium chloride as preservative and, therefore, should not be used to treat patients who wear soft contact lenses. Discontinue use if discomfort, increased reddening or irritation occurs and persists.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

Not applicable.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known


Go to top of the page
4.8 Undesirable effects

None known.


Go to top of the page
4.9 Overdose

None known.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Pharmacotherapeutic Group: Other Ophthalmologicals

ATC Code: S01X A08

Acetylcysteine, a derivative of the naturally occurring amino acid L-cysteine, is neither an enzyme nor a detergent.

Acetylcysteine has been shown to dramatically reduce the viscosity and tenacity of sputum. The liquefying action is due to the presence of a free sulphydryl group which opens up disulphide bonds present in mucus. This pharmacological action of acetylcysteine is of benefit to patients suffering from ocular mucus abnormality.

Acetylcysteine has marked mucolytic properties which reduce the viscosity and tenacity of mucus in the eyes. This combined with the emollient properties of hypromellose, ensures lubrication and soothing relief for dry eye syndrome.


Go to top of the page
5.2 Pharmacokinetic properties

No specific work has been carried out on the pharmacokinetic properties of acetylcysteine when used as a topical preparation for the eye. Acetylcysteine has marked mucolytic properties which reduce the viscosity and tenacity of mucus in the eye. This, combined with the emollient properties of hypromellose, ensures lubrication and soothing relief for dry eye syndromes.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Disodium edetate,

Hypromellose,

Benzalkonium chloride,

Sodium hydroxide,

Purified water.


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

2 years (unopened), 28 days (after first opening).


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.

Keep in the outer carton.

Keep container tightly closed.


Go to top of the page
6.5 Nature and contents of container

10 ml amber type I glass bottle with polypropylene screw cap lined with a rubber wad. The bottle and cap are closed with a tamper evident shrink-sleeve (alternatively tamper evidence is provided by the presence of a sticker covering the opening edge of the outer carton). The dropper assembly comprises a rubber teat, a plastic cap and a polycarbonate pipette.


Go to top of the page
6.6 Special precautions for disposal and other handling

Discard 28 days after first opening the pack.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Alcon Laboratories (UK) Ltd.,

Pentagon Park,

Boundary Way,

Hemel Hempstead,

Herts., HP2 7UD.

U.K.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00649/0144


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

22 December 1995


Go to top of the page
10. DATE OF REVISION OF THE TEXT

01/05/2008



More information about this product

Link to this document from your website: http://emc.medicines.org.uk/medicine/59/SPC/Ilube Eye Drops/


Active Ingredients/Generics

 
   acetylcysteine


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk